Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.
Historia zmian
First seen 28 Sept 2026, last checked 22 Nov 2026. 20 recorded versions.
- 22 Oct 2026 · 4dc95657ab2d
- 22 Oct 2026 · 2166a08c19eb
- 21 Oct 2026 · 0b8c1f3558c5
- 20 Oct 2026 · a59111f56fb6
- 19 Oct 2026 · 5f92e6b4ff14
- 18 Oct 2026 · 89fc79b4ca24
- 17 Oct 2026 · 10d3d60b1ddf
- 16 Oct 2026 · 9a55df4e5b84
- 15 Oct 2026 · 540ef584abfc
- 14 Oct 2026 · fa4ce06018bc
- 13 Oct 2026 · 62536ea45a93
- 12 Oct 2026 · aeaa67acd42c
- 11 Oct 2026 · 5d483c01b6c6
- 10 Oct 2026 · 732c318af221
- 09 Oct 2026 · aeaa67acd42c
- 08 Oct 2026 · e43abcafe786
- 07 Oct 2026 · aeaa67acd42c
- 06 Oct 2026 · 0f665d62f8c1
- 05 Oct 2026 · 5f92e6b4ff14
- 04 Oct 2026 · 2166a08c19eb